Selected research
Market Structure
Global Colchicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Colchicine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Colchicine include Yunnan Plant Medicine, Xishuangbanna Pharmaceutical, Takeda Pharmaceuticals, Tonghua Limin, Kunming Pharmaceutical, Beijing Jialin Pharmaceutical, Yunnan Shan State, Wockhardt and West-Ward, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Colchicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Colchicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Colchicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Colchicine market size, projected growth trends, production technologies, key applications, and end-use industries.
Colchicine Segment by Company
Yunnan Plant Medicine
Xishuangbanna Pharmaceutical
Takeda Pharmaceuticals
Tonghua Limin
Kunming Pharmaceutical
Beijing Jialin Pharmaceutical
Yunnan Shan State
Wockhardt
West-Ward
Rhea Pharmaceutical
Prasco
Odan Laboratories
Medinova
Hikma
Guangdong Pedi
Excellium Pharmaceutical
Cipla
Colchicine Segment by Type
Tablet
Oral Solution
Colchicine Segment by Application
Acute Gout
Chronic Gout
Other Conditions
Colchicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colchicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colchicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colchicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Colchicine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colchicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Colchicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Colchicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Oral Solution
Applications
- Acute Gout
- Chronic Gout
- Other Conditions
Companies covered
- Yunnan Plant Medicine
- Xishuangbanna Pharmaceutical
- Takeda Pharmaceuticals
- Tonghua Limin
- Kunming Pharmaceutical
- Beijing Jialin Pharmaceutical
- Yunnan Shan State
- Wockhardt
- West-Ward
- Rhea Pharmaceutical
- Prasco
- Odan Laboratories
- Medinova
- Hikma
- Guangdong Pedi
- Excellium Pharmaceutical
- Cipla
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Colchicine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Colchicine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Colchicine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Colchicine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Colchicine Market Dynamics
- 2.1 Colchicine Industry Trends
- 2.2 Colchicine Industry Drivers
- 2.3 Colchicine Industry Opportunities and Challenges
- 2.4 Colchicine Industry Restraints
3 Colchicine Market by Manufacturers
- 3.1 Global Colchicine Revenue by Manufacturers (2021-2026)
- 3.2 Global Colchicine Sales by Manufacturers (2021-2026)
- 3.3 Global Colchicine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Colchicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Colchicine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Colchicine Manufacturers, Product Type & Application
- 3.7 Global Colchicine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Colchicine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Colchicine Players Market Share by Revenue in 2025
- 3.8.3 2025 Colchicine Tier 1, Tier 2, and Tier 3
4 Colchicine Market by Type
- 4.1 Colchicine Type Introduction
- 4.1.1 Tablet
- 4.1.2 Oral Solution
- 4.2 Global Colchicine Sales by Type
- 4.2.1 Global Colchicine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Colchicine Sales by Type (2021-2032)
- 4.2.3 Global Colchicine Sales Market Share by Type (2021-2032)
- 4.3 Global Colchicine Revenue by Type
- 4.3.1 Global Colchicine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Colchicine Revenue by Type (2021-2032)
- 4.3.3 Global Colchicine Revenue Market Share by Type (2021-2032)
5 Colchicine Market by Application
- 5.1 Colchicine Application Introduction
- 5.1.1 Acute Gout
- 5.1.2 Chronic Gout
- 5.1.3 Other Conditions
- 5.2 Global Colchicine Sales by Application
- 5.2.1 Global Colchicine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Colchicine Sales by Application (2021-2032)
- 5.2.3 Global Colchicine Sales Market Share by Application (2021-2032)
- 5.3 Global Colchicine Revenue by Application
- 5.3.1 Global Colchicine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Colchicine Revenue by Application (2021-2032)
- 5.3.3 Global Colchicine Revenue Market Share by Application (2021-2032)
6 Global Colchicine Sales by Region
- 6.1 Global Colchicine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Colchicine Sales by Region (2021-2032)
- 6.2.1 Global Colchicine Sales by Region (2021-2026)
- 6.2.2 Global Colchicine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Colchicine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Colchicine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Colchicine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Colchicine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Colchicine Revenue by Region
- 7.1 Global Colchicine Revenue by Region
- 7.1.1 Global Colchicine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Colchicine Revenue by Region (2021-2026)
- 7.1.3 Global Colchicine Revenue by Region (2027-2032)
- 7.1.4 Global Colchicine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Colchicine Revenue (2021-2032)
- 7.2.2 North America Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Colchicine Revenue (2021-2032)
- 7.3.2 Europe Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Colchicine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Colchicine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yunnan Plant Medicine
- 8.1.1 Yunnan Plant Medicine Company Information
- 8.1.2 Yunnan Plant Medicine Business Overview
- 8.1.3 Yunnan Plant Medicine Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yunnan Plant Medicine Colchicine Product Portfolio
- 8.1.5 Yunnan Plant Medicine Recent Developments
- 8.2 Xishuangbanna Pharmaceutical
- 8.2.1 Xishuangbanna Pharmaceutical Company Information
- 8.2.2 Xishuangbanna Pharmaceutical Business Overview
- 8.2.3 Xishuangbanna Pharmaceutical Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Xishuangbanna Pharmaceutical Colchicine Product Portfolio
- 8.2.5 Xishuangbanna Pharmaceutical Recent Developments
- 8.3 Takeda Pharmaceuticals
- 8.3.1 Takeda Pharmaceuticals Company Information
- 8.3.2 Takeda Pharmaceuticals Business Overview
- 8.3.3 Takeda Pharmaceuticals Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Takeda Pharmaceuticals Colchicine Product Portfolio
- 8.3.5 Takeda Pharmaceuticals Recent Developments
- 8.4 Tonghua Limin
- 8.4.1 Tonghua Limin Company Information
- 8.4.2 Tonghua Limin Business Overview
- 8.4.3 Tonghua Limin Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Tonghua Limin Colchicine Product Portfolio
- 8.4.5 Tonghua Limin Recent Developments
- 8.5 Kunming Pharmaceutical
- 8.5.1 Kunming Pharmaceutical Company Information
- 8.5.2 Kunming Pharmaceutical Business Overview
- 8.5.3 Kunming Pharmaceutical Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Kunming Pharmaceutical Colchicine Product Portfolio
- 8.5.5 Kunming Pharmaceutical Recent Developments
- 8.6 Beijing Jialin Pharmaceutical
- 8.6.1 Beijing Jialin Pharmaceutical Company Information
- 8.6.2 Beijing Jialin Pharmaceutical Business Overview
- 8.6.3 Beijing Jialin Pharmaceutical Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Beijing Jialin Pharmaceutical Colchicine Product Portfolio
- 8.6.5 Beijing Jialin Pharmaceutical Recent Developments
- 8.7 Yunnan Shan State
- 8.7.1 Yunnan Shan State Company Information
- 8.7.2 Yunnan Shan State Business Overview
- 8.7.3 Yunnan Shan State Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Yunnan Shan State Colchicine Product Portfolio
- 8.7.5 Yunnan Shan State Recent Developments
- 8.8 Wockhardt
- 8.8.1 Wockhardt Company Information
- 8.8.2 Wockhardt Business Overview
- 8.8.3 Wockhardt Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Wockhardt Colchicine Product Portfolio
- 8.8.5 Wockhardt Recent Developments
- 8.9 West-Ward
- 8.9.1 West-Ward Company Information
- 8.9.2 West-Ward Business Overview
- 8.9.3 West-Ward Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 West-Ward Colchicine Product Portfolio
- 8.9.5 West-Ward Recent Developments
- 8.10 Rhea Pharmaceutical
- 8.10.1 Rhea Pharmaceutical Company Information
- 8.10.2 Rhea Pharmaceutical Business Overview
- 8.10.3 Rhea Pharmaceutical Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Rhea Pharmaceutical Colchicine Product Portfolio
- 8.10.5 Rhea Pharmaceutical Recent Developments
- 8.11 Prasco
- 8.11.1 Prasco Company Information
- 8.11.2 Prasco Business Overview
- 8.11.3 Prasco Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Prasco Colchicine Product Portfolio
- 8.11.5 Prasco Recent Developments
- 8.12 Odan Laboratories
- 8.12.1 Odan Laboratories Company Information
- 8.12.2 Odan Laboratories Business Overview
- 8.12.3 Odan Laboratories Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Odan Laboratories Colchicine Product Portfolio
- 8.12.5 Odan Laboratories Recent Developments
- 8.13 Medinova
- 8.13.1 Medinova Company Information
- 8.13.2 Medinova Business Overview
- 8.13.3 Medinova Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Medinova Colchicine Product Portfolio
- 8.13.5 Medinova Recent Developments
- 8.14 Hikma
- 8.14.1 Hikma Company Information
- 8.14.2 Hikma Business Overview
- 8.14.3 Hikma Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Hikma Colchicine Product Portfolio
- 8.14.5 Hikma Recent Developments
- 8.15 Guangdong Pedi
- 8.15.1 Guangdong Pedi Company Information
- 8.15.2 Guangdong Pedi Business Overview
- 8.15.3 Guangdong Pedi Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Guangdong Pedi Colchicine Product Portfolio
- 8.15.5 Guangdong Pedi Recent Developments
- 8.16 Excellium Pharmaceutical
- 8.16.1 Excellium Pharmaceutical Company Information
- 8.16.2 Excellium Pharmaceutical Business Overview
- 8.16.3 Excellium Pharmaceutical Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Excellium Pharmaceutical Colchicine Product Portfolio
- 8.16.5 Excellium Pharmaceutical Recent Developments
- 8.17 Cipla
- 8.17.1 Cipla Company Information
- 8.17.2 Cipla Business Overview
- 8.17.3 Cipla Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Cipla Colchicine Product Portfolio
- 8.17.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Colchicine Value Chain Analysis
- 9.1.1 Colchicine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Colchicine Production Mode & Process
- 9.2 Colchicine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Colchicine Distributors
- 9.2.3 Colchicine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst